WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
5,20 THB
0,00%
(0,00) 1K
15-okt, 16:40:00 (GMT+7) · THB
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoWUXI06 tikeri uchun statistika yaratilmoqda...
Ochish
5,25 THB
Yuqori
5,35 THB
Past
5,05 THB
Bozor kapitali
197,93 mlrd
Oʻrtacha hajm
93,60 ming
Hajmi
288,50 ming
52 haftalik eng yuqori
6,25 THB
52 haftalik eng past
3,02 THB
Muomaladagi aksiyalar
4,12 mlrd
Xodimlar soni
15 ming
Ochish
5,25 THB
Yuqori
5,35 THB
Past
5,05 THB
Bozor kapitali
197,93 mlrd
Oʻrtacha hajm
93,60 ming
Hajmi
288,50 ming
52 haftalik eng yuqori
6,25 THB
52 haftalik eng past
3,02 THB
Muomaladagi aksiyalar
4,12 mlrd
Xodimlar soni
15 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
TradingView
·
49 daqiqa oldin
Key facts: NASDAQ:ASTS delayed 2027; Piper Sandler Neutral; $1B note
Moomoo
·
44 daqiqa oldin
Dow Jones Top Company Headlines at 3 AM ET: Tesla's New Roadster Takes Flight After Nearly a Decade of Delays | Schneider ...
Kalkine Media
·
9 daqiqa oldin
Could Meta Platforms (NASDAQ:META) Be in Focus After Wall Street’s Latest Rotation?
Investor's Business Daily
·
4 soat oldin
Futures Mixed; Anthropic Value, Tesla Roadster In Focus
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Wuxi Biologics (Cayman) Inc. KKPS DR haqida
CEOZhisheng Chen
Xodimlar soni14,7 ming
Asos solingan2010
Bosh ofislar-
Sektor-
Veb-saytwuxibiologics.com